Evidence map›Paper›PMID 39878507›Full record

ArticleDisease models & mechanisms2025

Multi-omics analysis reveals distinct gene regulatory mechanisms between primary and organoid-derived human hepatocytes.

Haoyu Wu, Annie S P Yang, Suzan Stelloo, Floris J M Roos, René H M Te Morsche, Anne H Verkerk, Maria V Luna-Velez, Laura Wingens, Johannes H W de Wilt, Robert W Sauerwein and 6 more

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Haoyu WuDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Science, Radboud University, Nijmegen 6525GA, The Netherlands.ORCID 0000-0002-8995-3486
Annie S P YangCenter for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen 6500HB, The Netherlands.ORCID 0000-0002-7279-6058
Suzan StellooDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Science, Radboud University, Nijmegen 6525GA, The Netherlands.
Floris J M RoosDepartment of Surgery, Erasmus University Medical Center Transplant Institute, University Medical Center Rotterdam,Rotterdam 3000CA, TheNetherlands.
René H M Te MorscheDepartment of Gastroenterology and Hepatology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen 6500HB, The Netherlands.
Anne H VerkerkDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Science, Radboud University, Nijmegen 6525GA, The Netherlands.
Maria V Luna-VelezDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Science, Radboud University, Nijmegen 6525GA, The Netherlands.ORCID 0000-0002-0381-6246
Laura WingensDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6525GA, The Netherlands.
Johannes H W de WiltDepartment of Surgery, Radboud University Medical Center, Nijmegen 6500HB, The Netherlands.
Robert W SauerweinCenter for Infectious Diseases, Department of Medical Microbiology, Radboud University Medical Center, Nijmegen 6500HB, The Netherlands.
Klaas W MulderDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6525GA, The Netherlands.ORCID 0000-0001-8516-4458
Simon J van HeeringenDepartment of Molecular Developmental Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen 6525GA, The Netherlands.ORCID 0000-0002-0411-3219
Monique M A VerstegenDepartment of Surgery, Erasmus University Medical Center Transplant Institute, University Medical Center Rotterdam,Rotterdam 3000CA, TheNetherlands.
Luc J W van der LaanDepartment of Surgery, Erasmus University Medical Center Transplant Institute, University Medical Center Rotterdam,Rotterdam 3000CA, TheNetherlands.
Hendrik MarksDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Science, Radboud University, Nijmegen 6525GA, The Netherlands.ORCID 0000-0002-4198-3731
Richárd BártfaiDepartment of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Science, Radboud University, Nijmegen 6525GA, The Netherlands.ORCID 0000-0002-8460-6477

Funding

China Postdoctoral Science Foundation 2022M723171European Research Council 101118536-Host4Nederlandse Organisatie voor Wetenschappelijk Onderzoek 91218010Radboud Universiteit
6 · The paper itself

Abstract

Hepatic organoid cultures are a powerful model to study liver development and diseases in vitro. However, hepatocyte-like cells differentiated from these organoids remain immature compared to primary human hepatocytes (PHHs), which are the benchmark in the field. Here, we applied integrative single-cell transcriptome and chromatin accessibility analysis to reveal gene regulatory mechanisms underlying these differences. We found that, in mature human hepatocytes, activator protein 1 (AP-1) factors co-occupy regulatory regions with hepatocyte-specific transcription factors, including HNF4A, suggesting their potential cooperation in governing hepatic gene expression. Comparative analysis identified distinct transcription factor sets that are specifically active in either PHHs or intrahepatic cholangiocyte organoid (ICO)-derived human hepatocytes. ELF3 was one of the factors uniquely expressed in ICO-derived hepatocytes, and its expression negatively correlated with hepatic marker gene expression. Functional analysis further revealed that ELF3 depletion increased the expression of key hepatic markers in ICO-derived hepatocytes. Our integrative analysis provides insights into the transcriptional regulatory networks of PHHs and hepatic organoids, thereby informing future strategies for developing improved hepatic models.

Indexed as

Gene Expression RegulationGene Regulatory NetworksHepatocytesOrganoidsCell DifferentiationChromatinDNA-Binding ProteinsGene Expression ProfilingHepatocyte Nuclear Factor 4HumansMultiomicsProto-Oncogene Proteins c-etsSingle-Cell AnalysisTranscription Factor AP-1Transcription FactorsTranscriptomeChromatinDNA-Binding ProteinsELF3 protein, humanHepatocyte Nuclear Factor 4Proto-Oncogene Proteins c-etsTranscription Factor AP-1Transcription FactorsELF3Gene regulatory networkIntrahepatic cholangiocyte organoidsPrimary human hepatocytesscRNA-seq

Identifiers

PMID39878507
PMCPMC11810045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.